Contents
Download PDF
pdf Download XML
909 Views
63 Downloads
Share this article
Research Article | Volume 4 Issue 1 (Jan-June, 2024) | Pages 1 - 5
Determination of Hba1c, BMI and Blood Pressure Changes in Women with Gestational Diabetes Mellitus
 ,
1
Department of Biology, College of Science, University of Mosul, Mosul, Iraq, 41003
Under a Creative Commons license
Open Access
Received
Jan. 15, 2024
Revised
Feb. 16, 2024
Accepted
April 13, 2024
Published
May 30, 2024
Abstract

Gestational diabetes mellitus, Body Mass Index, HbA1c, Hypertension.

Keywords
Important Note:

Key findings:

Key findings include: significant increases in cumulative blood sugar (HbA1c) in women with gestational diabetes mellitus (GDM) in the second and third trimesters; significant increases in body mass index (BMI) in both GDM groups compared to the control group; and significant increases in systolic blood pressure in pregnant women with GDM, but within normal ranges.

 

What is known and what is new?

What is known is the prevalence and risks associated with gestational diabetes mellitus (GDM). What is new is the specific study investigating the relationship between HbA1c, BMI, and blood pressure in women with GDM, providing insights into the physiological changes and potential complications during pregnancy.

 

What is the implication, and what should change now?

The implication is that gestational diabetes mellitus (GDM) is associated with increased blood sugar, body mass index, and blood pressure. Changes needed include early detection and management of GDM to prevent complications, and healthcare providers should prioritize monitoring and controlling these factors to ensure better maternal and fetal outcomes.

INTRODUCTION:

Glycated hemoglobin A1C (HbA1c) has been widely used to monitor, screen and diagnose diabetes.  Increasing evidence has also shown that HbA1c can indicate glucose supply to the fetus.  Therefore, it is indicated that the HbA1c level at around 24 to 28 weeks may predict the development of fetal macrosomia or LGA in women with GDM, which may be beneficial for better prevention of fetal macrosomia and LGA [1]. Maternal obesity (body mass index (BMI >30 kg/m2) is a major public health concern that can predispose to higher rates of adverse pregnancy outcomes, especially the metabolic disorders of gestational diabetes mellitus (GDM) and preeclampsia [2]. In women, the rise in obesity has led to an increase in the incidence of gestational diabetes mellitus (GDM) as well as associated pregnancy and perinatal complications [3].Obesity has been mainly defined as an Increase in body fatness which leads to prolonged calorie overload at the expense of energy expenditure. Obesity has significant health-altering implications that have been shown to co-cause and develop other diseases through its wide-ranging physiological effects.  Obesity is associated with adverse perinatal outcomes and increased morbidity and mortality in pregnant women [4].Hypertensive disorders are among the most common medical conditions during pregnancy and are a major cause of death for mother and child.  Of concern is that high blood pressure is the most important risk factor for stroke, and there has been an overall rise in the incidence of pregnancy-related stroke in the past 20 years [5]. Several studies have shown that being overweight and obese before pregnancy increases the risk of major pregnancy complications such as high blood pressure and diabetes during pregnancy [6, 7]. Gestational Hypertension (GH) is another disorder of high blood pressure during pregnancy similar to preeclampsia, and gestational hypertension is defined as pregnancy-induced high blood pressure without proteinuria [8, 9].

MATERIAL AND METHOD:

 

 In this study, 70 blood samples were collected from pregnant women with gestational diabetes mellitus (GDM), whose ages ranged from (20-39) years. They were diagnosed by female doctors specializing In gynecology, obstetrics, and Infertility at Al-Wafa Health Center, Al-Batoul Hospital, Mosul General Hospital, and  Educational Specialist In Nineveh Governorate, based on clinical examination In addition to biochemical tests for the period from October (2023) to February (2024), and 50 blood samples were collected from healthy pregnant women who did not suffer from gestational diabetes and of the same ages and were considered a control group.  Relying on collecting information according to the questionnaire form, and after collecting venous blood from patients and control group, it was placed in EDTA tube (Ethylene Diamine Tetra Acetic Acid) with tight lids.  This part was used for the purpose of performing the HbA1c test.

 

2-1 Experimental Design 

          Control group

This group includes pregnant women (healthy women who do not suffer from gestational diabetes). This group was divided into two parts based on the Age as follow⁚

A- Group of healthy, pregnant women: Includes 25 pregnant women with age (20-29) years. 

 B- Group of healthy pregnant women: Includes 25 pregnant women with age (30-39) years.

 Group of women with gestational diabetes

 This group includes 70 pregnant women with gestational diabetes. This group was divided into two parts based on the Age⁚

 A-The group of pregnant women with gestational diabetes include 35 women with age (20-29) years. 

 B- The group of pregnant women with gestational diabetes includes 35 women aged (30-39) years. 

 

2-2 Biochemical Tests

         The following laboratory tests were performed: body mass Index (BMI) calculated by using a person's height and weight. The formula is BMI= Kg/m2. Estimation Glycohemoglobin HbA1c concentration was determined by using the BioHermes device from the Chinese company. Blood pressure was measured by using a sphygmomanometer from the Japanese company.

 

2-3 Statistical Analysis

Data were collected, reviewed, recorded, and entered Into the IBM SPSS statistical software application.  When the distribution of quantitative data was determined to be parametric, the means, standard deviations, and ranges were displayed.  Duncan's multiple range test showed that different letters of the alphabet significantly distinguished between different parameters at the probability level (P≤0.05), so a simple experimental system and a completely randomized design were used to analyze the data [10

RESULTS:

The results of the current study, as shown in the table (1), showed that there was a significant Increase in the concentration of glycated hemoglobin (HbA1c) in pregnant women with diabetes in the age group (20-29) and in the second and third trimesters at the probability level (P≤0.05), as the concentration of HbA1c in women with diabetes reached  Gestational diabetes in the second and third trimesters(7.08 ,7.54) respectively, compared to the control group (5.0, 5.22) respectively. While the HbA1c concentration reached in the age group (30-39) and in the second and third trimesters in women with gestational diabetes (7.53, 7.33) respectively compared to control (4.92, 5.18) respectively.

 

Table 1⁚ The value of study parameters

PatientsControlPatientsControl

Group

 

Parameter

30-39 years30-39 years20-29 years20-29 years
Third TrimesterSecond TrimesterThird TrimesterSecond Trimester

7.33±1.13

a

7.53±1.41

a

5.18±0.69

b

4.92±0.52

b

7.54±1.75

a

7.08±1.07

a

 

5.22±0.44

b

5.00±0.27

b

 

HbA1C

%

33.47±5.82

a

32.99±3.14

a

23.06±2.72

b

25.84±1.90

b

32.33±4.67

a

31.28±3.84

a

25.42±2.27

b

22.24±2.17

b

BMI

Kg/m²

12.60±1.26

a

12.60±1.42

a

11.40±0.89

ab

11.00±1.00

b

12.50±1.17

a

12.40±1.07

ab

11.20±0.83

ab

11.20±0.83

ab

Hypertention

mmHg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The no. followed by different letters means there is a significant difference. The values are means ± standard deviation SD.

The results in the table (1) also showed that there was a significant increase in body mass in the age group (20-29) and in the second and third trimesters at the probability level (P≤0.05), as the body mass in women with gestational diabetes reached (31.28, 32.33) kg/m² respectively, compared to control. (22.24, 25.42) kg/m², respectively. As for the age group (30-39), the body mass of women with gestational diabetes in the second and third trimesters reached (32.99, 33.47) kg/m², respectively, compared to control (25.84, 23.06) respectively.

The table (1) shows that there is a significant difference in systolic blood pressure in the age groups (20-29) and (30-39) and in the second and third trimesters in women with gestational diabetes, at the probability level (P≤0.05) compared to the control group

DISCUSSION:

 

The results in this study showed a significant increase in concentration of Glycohemoglobin (HbA1c) in the blood of pregnant women with gestational diabetes in both age groups (20-29) and (30-39) and in the second and third trimesters.  In pregnant women with gestational diabetes compared with control at the probability level (P≤0.05). 

 

The results of this study agreed with the findings of (Rayis et al., 2020; Wang et al., 2023) [11, 12].

 

This is because HbA1C is defined as a 3-month average measure of blood sugar control, [13].  Moreover, HbA1c is less sensitive in pregnant women due to iron deficiency and increased red blood cell turnover during pregnancy [14].  The advantage of HbA1c is that it is less affected by fluctuating post-meal glucose levels and other short-term changes caused by medical conditions.  However, there are still many factors that can affect HbA1c results, including hemoglobin variables and factors that affect the longevity of red blood cells.  HbA1c is also associated with adverse pregnancy outcomes and increased risk of gestational diabetes.  HbA1c may emerge as a diagnostic marker for GDM [15]. 

 

The results in table (1) showed a significant increase in the body mass of pregnant women with gestational diabetes in both age groups (20-29) and (30-39) and in the second and third trimesters compared with control at the probability level (P≤0.05).

 

 The results of this study were consistent with the findings of (Shi et al., 2021) [16], as he observed a significant increase in body mass. 

 

This is because obesity has negative short- and long-term consequences for both mothers and children.  Insulin resistance increases in early pregnancy, while glucose intolerance and fetal overgrowth occur in late pregnancy. Overweight and obesity before pregnancy can increase the risk of gestational diabetes and the rate of cesarean section (Ogburn, 2016).  It is known that the risk of GDM is increased among women who are overweight or obese compared to women who are thin or of normal weight.  Therefore, mechanisms linking obesity to insulin resistance, such as type 2 diabetes mellitus (T2DM), are likely to play a role in the development of GDM [18, 19].

 

The results of this study were consistent with the findings of (Szymanska et al., 2008) [20].

 

This is because high blood pressure is one of the main risk factors for cardiovascular disease, and high blood sugar and insulin resistance accelerate atherosclerosis, which increases the risk of high blood pressure. [21, 22]

 

Gestational diabetes mellitus (GDM) increases the risk of high blood pressure and cardiovascular events later in life.  [23

CONCLUSION:

The results confirmed that HbA1c and BMI were associated with gestational diabetes of pregnant women. They regarded risk factors for GDM. Systolic blood pressure of women with GDM stayed within the normal range.

 

Funding: No funding sources.

 

Conflict of interest: None declared.

 

Ethical approval: The study was approved by the Institutional Ethics Committee of University of Mosul.

REFERENCES:
  1. Mou, Sudipta Sarker, et al. "Association between HbA1c levels and fetal macrosomia and large for gestational age babies in women with gestational diabetes mellitus: a systematic review and meta-analysis of 17,711 Women." Journal of Clinical Medicine 12.11 (2023): 3852. https://doi.org/10.3390/jcm12113852 
  2. Torloni, M. R., et al. "Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta‐analysis." Obesity reviews 10.2 (2009): 194-203. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1467-789X.2008.00541.x 
  3. Pu, Jia, et al. "Racial/ethnic differences in gestational diabetes prevalence and contribution of common risk factors." Paediatric and perinatal epidemiology 29.5 (2015): 436-443. https://doi.org/10.1111/ppe.12209 
  4. Zehravi, Mehrukh, Mudasir Maqbool, and Irfat Ara. "Correlation between obesity, gestational diabetes mellitus, and pregnancy outcomes: an overview." International Journal of Adolescent Medicine and Health 33.6 (2021): 339-345. https://doi.org/10.1515/ijamh-2021-0058 
  5. Malha, Line, Tiina Podymow, and Phyllis August. "Hypertension in pregnancy." Hypertension. Elsevier, 2024. 501-517. https://doi.org/10.1016/B978-0-323-88369-6.00044-X 
  6. Vinayagam, D., et al. "Impaired maternal hemodynamics in morbidly obese women: a case–control study." Ultrasound in Obstetrics & Gynecology 50.6 (2017): 761-765. https://doi.org/10.1002/uog.17428 
  7. Yao, Da, et al. "Relationship between maternal central obesity and the risk of gestational diabetes mellitus: a systematic review and meta-analysis of cohort studies." Journal of diabetes research 2020 (2020). https://doi.org/10.1155/2020/6303820  
  8. Kurlak, Lesia O., et al. "Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease." Frontiers in physiology 5 (2014): 104129. https://doi.org/10.3389/fphys.2014.00310 
  9. Phoswa, Wendy N. "Dopamine in the pathophysiology of preeclampsia and gestational hypertension: monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT) as possible mechanisms." Oxidative Medicine and Cellular Longevity 2019 (2019). https://doi.org/10.1155/2019/3546294 
  10. S. Hommadi, ''Statistical Analysis forAgricultural Experiments'', (2017). 
  11. Rayis, Duria A., et al. "Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus." Journal of Clinical Laboratory Analysis 34.10 (2020): e23435. https://doi.org/10.1002/jcla.23435 
  12. Wang, Xinyue, et al. "Pre-pregnancy body mass index and glycated-hemoglobin with the risk of metabolic diseases in gestational diabetes: a prospective cohort study." Frontiers in Endocrinology 14 (2023): 1238873. https://doi.org/10.3389/fendo.2023.1238873 
  13. Homko, Carol J., et al. "Use of an internet-based telemedicine system to manage underserved women with gestational diabetes mellitus." Diabetes technology 
  14. & therapeutics 9.3 (2007): 297-306 https://www.liebertpub.com/doi/abs/10.1089/dia.2006.0034 
  15. Kohzuma, Takuji, and Masafumi Koga. "Lucica® GA-L Glycated Albumin Assay Kit: A New Diagnostic Test for Diabetes Mellitus." Molecular diagnosis & therapy 14 (2010): 49-51. https://link.springer.com/article/10.1007/BF03256353 
  16. Lau, C. S., and T. C. Aw. "HbA1c in the diagnosis and management of diabetes mellitus: an update." Diabetes 6 (2020): 1-4. https://www.siriusstore.com/pdf/DU-6-137.pdf 
  17. Shi, Ping, Aimin Liu, and Xiaoyan Yin. "Association between gestational weight gain in women with gestational diabetes mellitus and adverse pregnancy outcomes: a retrospective cohort study." BMC pregnancy and childbirth 21 (2021): 1-9. https://link.springer.com/article/10.1186/s12884-021-03982-4 
  18. Ogburn Jr, Paul L. "Obesity and gestational diabetes in pregnancy: an evolving epidemic." Journal of Perinatal Medicine 44.4 (2016): 361-362. https://doi.org/10.1515/jpm-2016-0117 
  19. Soheilykhah, Sedigheh, et al. "Maternal serum leptin concentration in gestational diabetes." Taiwanese Journal of Obstetrics and Gynecology 50.2 (2011): 149-153. https://doi.org/10.1016/j.tjog.2011.01.034 
  20. Xiao, L., et al. "Female fetus is associated with greater maternal insulin resistance in pregnancy." Diabetic medicine 31.12 (2014): 1696-1701. https://doi.org/10.1111/dme.12562 
  21. Szymanska, Monika, Dorota A. Bomba-Opon, and Miroslaw Wielgos. "Blood pressure and lipid changes in gestational diabetes mellitus." Neuroendocrinology Letters 29.3 (2008): 328-333. https://ppm.wum.edu.pl/docstore/download/WUMe31ed6d57f834e8ca1e54dc44adba46e/A63F8F70-55EA-4752-AA03-79343EB283BA.pdf 
  22. Kearney, Patricia M., et al. "Global burden of hypertension: analysis of worldwide data." The lancet 365.9455 (2005): 217-223. https://doi.org/10.1016/S0140-6736(05)17741-1 
  23. Ferrannini, Ele, and William C. Cushman. "Diabetes and hypertension: the bad companions." The Lancet 380.9841 (2012): 601-610. https://doi.org/10.1016/S0140-6736(12)60987-8 
  24. Guo, Jia, et al. "Biological and sociocultural determinants of increased blood pressure among women with a history of gestational diabetes mellitus in rural China: a retrospective cohort study." BMJ open 12.1 (2022): e049625. https://doi.org/10.1136/bmjopen-2021-049625 

     

Recommended Articles
Research Article
Histopathological Spectrum of Endometrial Biopsies in Abnormal Uterine Bleeding in Mosul City Iraq
Published: 30/06/2026
Download PDF
Research Article
A Study on the Levels for mRNA Gene Expression of NF-κB and miR-34a Genes in Human Patients with Breast Cancer: An Indication for Resistance to Chemotherapy
Published: 15/12/2023
Download PDF
Research Article
Molecular Study to Detect Some Virulence Factors in Methicillin – Resistance Staphlococcus Aureus Isolated from Eye Infections in Wasit Province
Published: 15/12/2023
Download PDF
Research Article
Occurrence of Multi-Drug Resistance of E. coli Isolated from Urinary Tract Infection in Najaf City
...
Published: 05/10/2025
Download PDF
Chat on WhatsApp
Flowbite Logo
PO Box 101, Nakuru
Kenya.
Email: office@iarconsortium.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Shipping Policy
Others
About Us
Team Members
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
+91 60029-93949
Follow us
MOST SEARCHED KEYWORDS
Copyright © iARCON International LLP . All Rights Reserved.